FDA Approved: RUBRACA — Supplemental Application (pharmaand GmbH)

View source ↗

Summary

The FDA approved a supplemental application for RUBRACA (rucaparib) submitted by pharmaand GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• RUBRACA (RUCAPARIB)

Snippet

SUPPL AP for RUBRACA (RUCAPARIB)